| Item Type | Name |
|
Concept
|
Age Factors
|
|
Concept
|
Acetylcysteine
|
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Arthritis, Rheumatoid
|
|
Concept
|
Biopsy
|
|
Concept
|
Carbon Monoxide
|
|
Concept
|
Chicago
|
|
Concept
|
Connective Tissue Diseases
|
|
Concept
|
Cause of Death
|
|
Concept
|
Echocardiography
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Lung Volume Measurements
|
|
Concept
|
Diagnostic Imaging
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Influenza, Human
|
|
Concept
|
Gene Expression Regulation
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Obesity
|
|
Concept
|
Environmental Exposure
|
|
Concept
|
Health Services Accessibility
|
|
Concept
|
Lung Diseases
|
|
Concept
|
Leukocytes
|
|
Concept
|
Pneumonia, Viral
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mutation
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Practice Patterns, Physicians'
|
|
Concept
|
Polymorphism, Genetic
|
|
Concept
|
Oxygen
|
|
Concept
|
Pulmonary Emphysema
|
|
Concept
|
Radiographic Image Enhancement
|
|
Concept
|
Registries
|
|
Concept
|
Risk Factors
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Scleroderma, Systemic
|
|
Concept
|
Respiratory Function Tests
|
|
Concept
|
Seasons
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Humans
|
|
Concept
|
Hypertension, Pulmonary
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Statistics as Topic
|
|
Concept
|
Practice Guidelines as Topic
|
|
Concept
|
Genetic Variation
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Antibodies, Antineutrophil Cytoplasmic
|
|
Concept
|
Echocardiography, Three-Dimensional
|
|
Concept
|
Inhalation Exposure
|
|
Concept
|
Matrix Metalloproteinase 7
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Prevalence
|
|
Concept
|
Fatty Acids, Omega-3
|
|
Concept
|
Observer Variation
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Mortality
|
|
Concept
|
Comorbidity
|
|
Concept
|
Occupational Exposure
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Minority Groups
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Telomerase
|
|
Concept
|
CA-125 Antigen
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Myeloblastin
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
Inducible T-Cell Co-Stimulator Protein
|
|
Concept
|
Clinical Laboratory Techniques
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Mice
|
|
Concept
|
Pulmonary Diffusing Capacity
|
|
Concept
|
Rheumatoid Factor
|
|
Concept
|
Mucin-5B
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Chemokine CXCL13
|
|
Concept
|
Idiopathic Interstitial Pneumonias
|
|
Concept
|
Acute Lung Injury
|
|
Concept
|
Propensity Score
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Kruppel-Like Transcription Factors
|
|
Concept
|
Sex Factors
|
|
Concept
|
Vital Capacity
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Lung Diseases, Interstitial
|
|
Concept
|
Survival Rate
|
|
Concept
|
Early Detection of Cancer
|
|
Concept
|
Vascular Cell Adhesion Molecule-1
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Transcriptome
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
STAT6 Transcription Factor
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
rho-Associated Kinases
|
|
Concept
|
Idiopathic Pulmonary Fibrosis
|
|
Concept
|
Alveolitis, Extrinsic Allergic
|
|
Concept
|
Antibodies, Antinuclear
|
|
Concept
|
Autopsy
|
|
Concept
|
Diagnostic Tests, Routine
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
DNA Helicases
|
|
Concept
|
Exoribonucleases
|
|
Concept
|
Genotype
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Patient Compliance
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Pulmonary Fibrosis
|
|
Concept
|
Pyridones
|
|
Concept
|
Respiration, Artificial
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Serine Endopeptidases
|
|
Concept
|
Radiography, Thoracic
|
|
Concept
|
Eicosapentaenoic Acid
|
|
Concept
|
Interleukin-5
|
|
Concept
|
Cytokines
|
|
Concept
|
Telomere
|
|
Concept
|
Hospital Mortality
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Genomics
|
|
Academic Article
|
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort.
|
|
Academic Article
|
N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.
|
|
Academic Article
|
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
|
|
Academic Article
|
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.
|
|
Academic Article
|
Telomere length and genetic variant associations with interstitial lung disease progression and survival.
|
|
Academic Article
|
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
|
|
Academic Article
|
Reply to Lescoat et al. and to Khamis et al.
|
|
Academic Article
|
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
|
|
Academic Article
|
Anti-RNA binding protein positivity in idiopathic interstitial pneumonia.
|
|
Academic Article
|
Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.
|
|
Academic Article
|
Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.
|
|
Academic Article
|
Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease.
|
|
Academic Article
|
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
|
|
Academic Article
|
Diagnostic test interpretation and referral delay in patients with interstitial lung disease.
|
|
Academic Article
|
CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA.
|
|
Academic Article
|
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.
|
|
Academic Article
|
MUC5B promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosis.
|
|
Academic Article
|
The role of echocardiography in the evaluation and management of aortic stenosis in the older adult.
|
|
Academic Article
|
Diagnostic Delay in Idiopathic Pulmonary Fibrosis: Where the Rubber Meets the Road.
|
|
Academic Article
|
Association of Black Race with Outcomes in COVID-19 Disease: A Retrospective Cohort Study.
|
|
Academic Article
|
Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype.
|
|
Grant
|
Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
|
|
Academic Article
|
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.
|
|
Academic Article
|
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis.
|
|
Academic Article
|
Automated CT Analysis of Major Forms of Interstitial Lung Disease.
|
|
Academic Article
|
SARS-CoV-2 infection reduces Krüppel-Like Factor 2 in human lung autopsy.
|
|
Academic Article
|
Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.
|
|
Academic Article
|
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
|
|
Academic Article
|
Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.
|
|
Academic Article
|
A series of COVID-19 autopsies with clinical and pathologic comparisons to both seasonal and pandemic influenza.
|
|
Academic Article
|
Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies.
|
|
Academic Article
|
SARS-CoV-2 Infection Is Associated with Reduced Krüppel-like Factor 2 in Human Lung Autopsy.
|
|
Academic Article
|
Correction to: Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.
|
|
Academic Article
|
Anticoagulation and Pulmonary Fibrosis: Friends, Foes, or Functional Allies?
|
|
Academic Article
|
Diagnostic Classification of Interstitial Lung Disease in Clinical Practice.
|
|
Academic Article
|
Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
|
|
Academic Article
|
Risk, Race, and Structural Racism.
|
|
Academic Article
|
The Progression to Interstitial Lung Disease: Vicarious Facts About Visceral Fat.
|
|
Academic Article
|
Treatment of fibrotic interstitial lung disease: current approaches and future directions.
|
|
Academic Article
|
Hospitalizations in patients with idiopathic pulmonary fibrosis.
|
|
Academic Article
|
Rituximab for interstitial pneumonia with autoimmune features at two medical centres.
|
|
Academic Article
|
High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
|
|
Academic Article
|
Lung function trajectory in progressive fibrosing interstitial lung disease.
|
|
Academic Article
|
Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease.
|
|
Academic Article
|
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.
|
|
Academic Article
|
Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward.
|
|
Academic Article
|
Racial Disparities in Pulmonary Fibrosis and the Impact on the Black Population.
|
|
Academic Article
|
Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard.
|
|
Academic Article
|
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
|
|
Academic Article
|
Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease.
|
|
Academic Article
|
Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
|
|
Academic Article
|
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
|
|
Academic Article
|
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study.
|
|
Academic Article
|
MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study.
|
|
Academic Article
|
Updated Imaging Classification of Hypersensitivity Pneumonitis.
|
|
Academic Article
|
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.
|
|
Academic Article
|
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.
|
|
Academic Article
|
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults.
|
|
Concept
|
Rituximab
|
|
Concept
|
Tobacco Smoking
|
|
Academic Article
|
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts.
|
|
Academic Article
|
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.
|
|
Academic Article
|
Racial Disparities Among Lung Transplant Survivors-Shadows and Substance.
|
|
Academic Article
|
Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies.
|
|
Academic Article
|
Interstitial lung disease: a decade of progress and hope.
|
|
Academic Article
|
Towards a Race-Neutral System of Pulmonary Function Test Results Interpretation.
|
|
Academic Article
|
Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.
|
|
Academic Article
|
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
|
|
Academic Article
|
Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis.
|
|
Academic Article
|
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States.
|
|
Academic Article
|
Identification of Clinically Significant Cytokine Signature Clusters in Patients With Septic Shock.
|
|
Academic Article
|
Induced Pluripotent Stem Cells in Disease Biology and the Evidence for Their In Vitro Utility.
|
|
Academic Article
|
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.
|
|
Academic Article
|
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.
|
|
Academic Article
|
Peripheral Blood Single-Cell Sequencing Uncovers Common and Specific Immune Aberrations in Fibrotic Lung Diseases.
|
|
Academic Article
|
Computer-Aided Pulmonary Fibrosis Detection Leveraging an Advanced Artificial Intelligence Triage and Notification Software.
|
|
Academic Article
|
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection-response to Guangting Zeng and Yuchi Zhou.
|
|
Academic Article
|
A Deep Learning-Based Radiomic Classifier for Usual Interstitial Pneumonia.
|
|
Academic Article
|
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
|
|
Academic Article
|
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis.
|
|
Academic Article
|
Home Oxygen After Hospitalization for COVID-19: Results From the Multi-Center OXFORD Study.
|
|
Academic Article
|
Risk Factors for Hospital Readmission in Patients with Interstitial Lung Disease.
|
|
Academic Article
|
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
|
|
Academic Article
|
Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
|
|
Academic Article
|
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis.
|
|
Academic Article
|
Implementation of an Interstitial Lung Abnormality Clinic and Multidisciplinary Discussion.
|
|
Academic Article
|
Response.
|
|
Academic Article
|
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis.
|
|
Academic Article
|
Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis.
|
|
Academic Article
|
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.
|
|
Academic Article
|
The Role of Inflammation and Fibrosis in ILD Treatment Decisions.
|
|
Academic Article
|
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.
|
|
Academic Article
|
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis.
|